Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0001209191-14-059630

Options or other derivatives

  • President and CEO acquired 165,251 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Morrison Jodie Pope President and CEO 2014-09-22 Grant or award · Stock Option (right to buy) +165,251 165,251 D: show line 1 in the form
Loading xslF345X03/doc4.xml…